MUC1 expression and anti-MUC1 serum immune response in head and neck squamous cell carcinoma (HNSCC): a multivariate analysis
<p>Abstract</p> <p>Background</p> <p>HNSCC progression to adjacent tissue and nodes may be mediated by altered glycoproteins and glycolipids such as MUC1 mucin. This report constitutes a detailed statistical study about MUC1 expression and anti-MUC1 immune responses in...
Main Authors: | Segal-Eiras Amada, Pereyra Adrián, Croce María V, Rabassa Martín E |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-10-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/6/253 |
Similar Items
-
MUC1 confers radioresistance in head and neck squamous cell carcinoma (HNSCC) cells
by: Tian-qiao Huang, et al.
Published: (2020-01-01) -
MUC1 as a target for CAR‐T therapy in head and neck squamous cell carinoma
by: Zi Mei, et al.
Published: (2020-01-01) -
Immunohistochemical evidence of Muc1 expression during rat embryonic development
by: E. Lacunza, et al.
Published: (2010-11-01) -
Proteolytic cleavage sites in MUC1,MUC3,MUC4 and MUC12 membrane-tethered mucins
by: Palmai-Pallag, Timea
Published: (2008) -
Features of MUC1, MUC2, MUC4 and MUC5AC mucins in HNPCC and sporadic colorectal carcinomas
by: Juin-Ting Liu, et al.
Published: (2003)